Alana Harris Dent

Array ( [id] => 5204990 [patent_doc_number] => 20070026471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Glypican-1 in human breast cancer' [patent_app_type] => utility [patent_app_number] => 11/523174 [patent_app_country] => US [patent_app_date] => 2006-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 15829 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026471.pdf [firstpage_image] =>[orig_patent_app_number] => 11523174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4445364 [patent_doc_number] => 07863424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma' [patent_app_type] => utility [patent_app_number] => 11/520183 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 56 [patent_no_of_words] => 23214 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863424.pdf [firstpage_image] =>[orig_patent_app_number] => 11520183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555288 [patent_doc_number] => 08067189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV' [patent_app_type] => utility [patent_app_number] => 11/991351 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16441 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067189.pdf [firstpage_image] =>[orig_patent_app_number] => 11991351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733778 [patent_doc_number] => 20080050757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'RAPID METHOD FOR DETECTING MUTATED GENES' [patent_app_type] => utility [patent_app_number] => 11/466710 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3533 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050757.pdf [firstpage_image] =>[orig_patent_app_number] => 11466710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404492 [patent_doc_number] => 20090239806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'GLYPICAN-3 (GPC3)-DERIVED TUMOR REJECTION ANTIGENIC PEPTIDES USEFUL FOR HLA-A2-POSITIVE PATIENTS AND PHARMACEUTICAL COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/063165 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7189 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239806.pdf [firstpage_image] =>[orig_patent_app_number] => 12063165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589065 [patent_doc_number] => 08778606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'At-home cancer test' [patent_app_type] => utility [patent_app_number] => 11/493651 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2198 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11493651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373613 [patent_doc_number] => 20090311174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Method For Treating Cancer' [patent_app_type] => utility [patent_app_number] => 11/996270 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11162 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311174.pdf [firstpage_image] =>[orig_patent_app_number] => 11996270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811162 [patent_doc_number] => 08133692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Methods of predicting responsiveness to chemotherapeutic agents and selecting treatments' [patent_app_type] => utility [patent_app_number] => 11/490316 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14225 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133692.pdf [firstpage_image] =>[orig_patent_app_number] => 11490316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5348801 [patent_doc_number] => 20090004162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Hecgf-1 Related Polymorphisms and Applications Thereof' [patent_app_type] => utility [patent_app_number] => 11/993886 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11058 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004162.pdf [firstpage_image] =>[orig_patent_app_number] => 11993886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6417848 [patent_doc_number] => 20100167324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Quantitative Assays for Ras p21 in Body Fluids' [patent_app_type] => utility [patent_app_number] => 11/917471 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14224 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167324.pdf [firstpage_image] =>[orig_patent_app_number] => 11917471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479605 [patent_doc_number] => 20090202562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'ANTI-GFRALPHA3 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/917676 [patent_app_country] => US [patent_app_date] => 2006-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9962 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202562.pdf [firstpage_image] =>[orig_patent_app_number] => 11917676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538727 [patent_doc_number] => 20090220532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Agents and methods based on the use of the eda domian of fibronectin' [patent_app_type] => utility [patent_app_number] => 11/922148 [patent_app_country] => US [patent_app_date] => 2006-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13534 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220532.pdf [firstpage_image] =>[orig_patent_app_number] => 11922148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328828 [patent_doc_number] => 08236928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Genes differentially expressed in breast cancer' [patent_app_type] => utility [patent_app_number] => 11/450251 [patent_app_country] => US [patent_app_date] => 2006-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 12701 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11450251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533030 [patent_doc_number] => 20090232818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Prognosis and Treatment of Breast Cancer' [patent_app_type] => utility [patent_app_number] => 11/912413 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15896 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232818.pdf [firstpage_image] =>[orig_patent_app_number] => 11912413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415868 [patent_doc_number] => 20090041755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Methods and Compositions For PDGF-D Activation and Inhibition' [patent_app_type] => utility [patent_app_number] => 11/914036 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7012 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041755.pdf [firstpage_image] =>[orig_patent_app_number] => 11914036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732200 [patent_doc_number] => 20060257317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Combination therapy in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/416633 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9107 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257317.pdf [firstpage_image] =>[orig_patent_app_number] => 11416633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779359 [patent_doc_number] => 20080287357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Conjugate Comprising P21 Protein for the Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 11/911427 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5579 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287357.pdf [firstpage_image] =>[orig_patent_app_number] => 11911427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23193 [patent_doc_number] => 07794926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Detection of survivin in the biological fluids of cancer patients' [patent_app_type] => utility [patent_app_number] => 11/405694 [patent_app_country] => US [patent_app_date] => 2006-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10942 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794926.pdf [firstpage_image] =>[orig_patent_app_number] => 11405694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965749 [patent_doc_number] => 20080108569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Compositions and Methods for Treating Diseases Associated With Phlpp' [patent_app_type] => utility [patent_app_number] => 11/910389 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 32527 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108569.pdf [firstpage_image] =>[orig_patent_app_number] => 11910389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284862 [patent_doc_number] => 20090098537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Biomarker for Sensitivity to mTOR Inhibitor Therapy in Kidney Cancer' [patent_app_type] => utility [patent_app_number] => 11/886444 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15300 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098537.pdf [firstpage_image] =>[orig_patent_app_number] => 11886444 [rel_patent_id] =>[rel_patent_doc_number] =>)